2024
2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache.
Sico J, Antonovich N, Ballard-Hernandez J, Buelt A, Grinberg A, Macedo F, Pace I, Reston J, Sall J, Sandbrink F, Skop K, Stark T, Vogsland R, Wayman L, Ford A. 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache. Annals Of Internal Medicine 2024 PMID: 39467289, DOI: 10.7326/annals-24-00551.Peer-Reviewed Original ResearchClinical practice guidelinesU.S. Department of Veterans AffairsTension-type headacheDepartment of Veterans AffairsVeterans AffairsManagement of headacheCalcitonin gene-related peptidePractice guidelinesEpisodic migraineDefense Clinical Practice GuidelinesPrimary care cliniciansManagement of tension-type headacheRevised CPGTreatment of tension-type headacheDepartment of Defense Clinical Practice GuidelinesChronic tension-type headacheCalcitonin gene-related peptide monoclonal antibodiesTreatment of acute migrainePrevention of chronic migraineAerobic exerciseCare cliniciansPreventing episodic migrainePhysical therapyNonpharmacological interventionsSecondary headache disorders
2022
The Primary Care Management of Headache: Synopsis of the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
Sico JJ, Macedo F, Lewis J, Spevak C, Vogsland R, Ford A, Skop K, Sall J. The Primary Care Management of Headache: Synopsis of the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Military Medicine 2022, 187: e1091-e1102. PMID: 35022782, DOI: 10.1093/milmed/usab490.Peer-Reviewed Original ResearchConceptsClinical practice guidelinesPractice guidelinesDefense Clinical Practice GuidelineJoint clinical practice guidelineTrustworthy clinical practice guidelinesPractice Work GroupMedication overuse headachePrimary care managementPreferences of patientsGuideline development panelMedicine's tenetsPharmacologic managementRecommendations AssessmentOveruse headacheGuideline panelCare managementHeadacheDevelopment panelVeterans AffairsClinical stakeholdersPatientsGuidelinesIndividual needsDepartmentPrevention
2021
Deintensification or No Statin Treatment Is Associated With Higher Mortality in Patients With Ischemic Stroke or Transient Ischemic Attack
Dearborn-Tomazos JL, Hu X, Bravata DM, Phadke MA, Baye FM, Myers LJ, Concato J, Zillich AJ, Reeves MJ, Sico JJ. Deintensification or No Statin Treatment Is Associated With Higher Mortality in Patients With Ischemic Stroke or Transient Ischemic Attack. Stroke 2021, 52: 2521-2529. PMID: 34015937, DOI: 10.1161/strokeaha.120.030089.Peer-Reviewed Original ResearchConceptsTransient ischemic attackIschemic strokeIschemic attackHospital dischargeHospital admissionHigh mortalityVeterans Health Administration facilitiesHigh-potency statinsUnderutilization of statinsHigh potencyStatin doseStatin medicationBaseline characteristicsMost patientsPrescribed statinsStatin treatmentPharmacy filesStatin potencyAtherosclerotic originUS veteransPractice guidelinesStudy populationHigher oddsPatientsStatins